Intravenous anti-P. aeruginosa IgY-antibodies do not decrease pulmonary bacterial concentrations in a porcine model of ventilator-associated pneumonia

Ventilator associated pneumonia (VAP) caused by P. aeruginosa is a cause of morbidity and mortality in critically ill patients. The spread of pathogens with anti-microbial resistance mandates the investigation of novel therapies. Specific polyclonal anti-P. aeruginosa IgY-antibodies (Pa-IgY) might b...

Descripción completa

Detalles Bibliográficos
Autores principales: Otterbeck, A., Skorup, P., Hanslin, K., Larsson, A., Stålberg, J., Hjelmqvist, H., Lipcsey, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900256/
https://www.ncbi.nlm.nih.gov/pubmed/36373663
http://dx.doi.org/10.1177/17534259221114217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900256/
https://www.ncbi.nlm.nih.gov/pubmed/36373663
http://dx.doi.org/10.1177/17534259221114217

Ejemplares similares